公开(公告)号：US20080153786A1

公开(公告)日：2008-06-26

申请号：US12000187

申请日：2007-12-10

Applicant: Philippe Andres ,  Claire Mallard

Inventor： Philippe Andres ,  Claire Mallard

IPC: A61K31/59 ,  A61P17/02 ,  A61P17/06

CPC classification number: A61K31/59 ,  A61K9/0014 ,  A61K9/06

Abstract: The slow and sustained, controlled release of a drug into and through the skin includes topically applying onto the skin of an individual in need of such treatment, a composition containing at least one solubilized drug, at least one film-forming silicone, and at least one volatile solvent.

Abstract translation: 将药物缓慢且持续地控制释放到皮肤中并通过皮肤包括局部施用于需要这种治疗的个体的皮肤上，含有至少一种溶解药物，至少一种成膜硅氧烷的组合物，至少 一种挥发性溶剂。

公开(公告)号：US20050282792A1

公开(公告)日：2005-12-22

申请号：US10942997

申请日：2004-09-17

Applicant: Philippe Andres

Inventor： Philippe Andres

IPC: A61K31/573 ,  A61K31/59

CPC classification number: A61K31/573 ,  A61K31/59 ,  A61K2300/00

Abstract: Topically applicable pharmaceutical compositions useful for the treatment of psoriasis contain respective amounts of calcitriol and clobetasol propionate permitting a once-per-day effective regimen of topical application onto the part or parts of the skin affected by psoriasis.

Abstract translation: 可用于治疗牛皮癣的局部适用的药物组合物含有相应量的骨化三醇和丙酸氯倍他索，其允许每天一次有效的局部施用方案施用于受牛皮癣影响的皮肤的部分或部分上。

公开(公告)号：US20110224216A1

公开(公告)日：2011-09-15

申请号：US12907543

申请日：2010-10-19

Applicant: Philippe Andres ,  Christian Loesche ,  Michael Graeber

Inventor： Philippe Andres ,  Christian Loesche ,  Michael Graeber

IPC: A61K31/498 ,  A61P17/00 ,  A61P29/00

CPC classification number: A61K31/498 ,  A61K31/4164

Abstract: A method of treating or preventing acute erythema in a human in need thereof by topical administration of an effective amount of an alpha adrenergic receptor agonist or pharmaceutically acceptable salt thereof is claimed. The preferred alpha adrenergic receptor agonist is brimonidine. A method of preventing secondary inflammation caused by acute erythema by topical administration of an effective amount of an alpha adrenergic receptor agonist or a pharmaceutically acceptable salt thereof is also claimed.

Abstract translation: 一种通过局部施用有效量的α肾上腺素能受体激动剂或其药学上可接受的盐来治疗或预防有此需要的人的急性红斑的方法。 优选的α肾上腺素能受体激动剂是溴莫尼定。 还要求保护通过局部施用有效量的α肾上腺素能受体激动剂或其药学上可接受的盐来预防由急性红斑引起的继发性炎症的方法。

公开(公告)号：US20100284581A1

公开(公告)日：2010-11-11

申请号：US12599618

申请日：2008-05-28

Applicant: Laurent Petit ,  Philippe Andres

Inventor： Laurent Petit ,  Philippe Andres

IPC: G06K9/00

CPC classification number: G06T11/00 ,  A61B5/0059 ,  A61B5/445 ,  G06F19/321

Abstract: This method for acquiring and processing data for detecting the change over time of changing lesions includes: successive data acquisitions according to different acquisition methods, so that, at each moment of acquisition, the user forms a set of data obtained according to respective acquisition methods; storage of the acquired data in a database; and displaying the data by selecting and displaying the selected data on a display screen. During displaying an item of data, the user inserts into an image being displayed at least one matching data item extracted from the database.

Abstract translation: 用于获取和处理用于检测变化的病变随时间变化的数据的方法包括：根据不同的获取方法进行连续的数据采集，使得在每个采集时刻，用户形成根据各自的获取方法获得的一组数据; 将获取的数据存储在数据库中; 并通过在显示屏幕上选择和显示所选择的数据来显示数据。 在显示数据项期间，用户插入正在显示从数据库提取的至少一个匹配数据项的图像。

公开(公告)号：US20110274727A1

公开(公告)日：2011-11-10

申请号：US13126215

申请日：2009-10-28

Applicant: Philippe Andres ,  Isabelle Pelisson

Inventor： Philippe Andres ,  Isabelle Pelisson

IPC: A61K9/00 ,  A61P17/12 ,  A61Q19/02 ,  A61K8/34 ,  A61P17/00

CPC classification number: A61K8/347 ,  A61K9/0014 ,  A61Q19/02

Abstract: Depigmenting topical compositions and their uses are described. In particular, the described compositions can provide improved effectiveness in the dermatological treatment of pigmentation, without disadvantages experienced with other known compositions. The described topical compositions can comprise, in a physiologically acceptable medium, from 3% to 10% of rucinol or one of its salts. Also described, are methods of use treating pigmentation disorders of the skin with the described compositions.

Abstract translation: 描述脱色局部组合物及其用途。 特别地，所描述的组合物可以在色素沉着的皮肤病学治疗中提供改进的有效性，而没有其它已知组合物所经历的缺点。 所述的局部组合物可以在生理上可接受的介质中包含3％至10％的人参因子或其盐之一。 还描述了使用所述组合物治疗皮肤色素沉着病症的方法。

公开(公告)号：US20100216753A1

公开(公告)日：2010-08-26

申请号：US12714739

申请日：2010-03-01

Applicant: Philippe Andres ,  Claire Mallard

Inventor： Philippe Andres ,  Claire Mallard

IPC: A61K31/569 ,  A61P17/06

CPC classification number: A61K31/59 ,  A61K9/0014 ,  A61K9/06

Abstract: The slow and sustained, controlled release of a drug into and through the skin includes topically applying onto the skin of an individual in need of such treatment, a composition containing at least one solubilized drug, at least one film-forming silicone, and at least one volatile solvent.

Abstract translation: 将药物缓慢且持续地控制释放到皮肤中并通过皮肤包括局部施用于需要这种治疗的个体的皮肤上，含有至少一种溶解药物，至少一种成膜硅氧烷的组合物，至少 一种挥发性溶剂。